Search research articles
Contact Us
Filters
Showing results (131-140 of 137) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 137 results.
Clinical Journal of the American Society of Nephrology : CJASN
|
July 1, 2022
Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis
Hannah J Lomax-Browne, Nicholas R Medjeral-Thomas, Sean J Barbour, et al.
The New England Journal of Medicine
|
December 3, 2025
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN
Fadi Fakhouri, Andrew S Bomback, Gema Ariceta, et al.
Cell Genomics
|
June 18, 2025
Temporal multi-omics analysis of COVID-19 in end-stage kidney disease
Emily Stephenson, Erin Macdonald-Dunlop, Lisa M Dratva, et al.
Journal of the American Society of Nephrology : JASN
|
August 7, 2007
New approaches to the treatment of dense deposit disease
Richard J H Smith, Jessy Alexander, Paul N Barlow, et al.
Nature
|
August 14, 2024
Recognition and control of neutrophil extracellular trap formation by MICL
Mariano Malamud, Lauren Whitehead, Alasdair McIntosh, et al.
Kidney International
|
November 1, 2013
C3 glomerulopathy: consensus report
Matthew C Pickering, Vivette D D'Agati, Carla M Nester, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 27, 2021
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
Andrew S Bomback, Gerald B Appel, Debbie S Gipson, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 137) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 137 results.
Clinical Journal of the American Society of Nephrology : CJASN
|
July 1, 2022
Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis
Hannah J Lomax-Browne, Nicholas R Medjeral-Thomas, Sean J Barbour, et al.
The New England Journal of Medicine
|
December 3, 2025
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN
Fadi Fakhouri, Andrew S Bomback, Gema Ariceta, et al.
Cell Genomics
|
June 18, 2025
Temporal multi-omics analysis of COVID-19 in end-stage kidney disease
Emily Stephenson, Erin Macdonald-Dunlop, Lisa M Dratva, et al.
Journal of the American Society of Nephrology : JASN
|
August 7, 2007
New approaches to the treatment of dense deposit disease
Richard J H Smith, Jessy Alexander, Paul N Barlow, et al.
Nature
|
August 14, 2024
Recognition and control of neutrophil extracellular trap formation by MICL
Mariano Malamud, Lauren Whitehead, Alasdair McIntosh, et al.
Kidney International
|
November 1, 2013
C3 glomerulopathy: consensus report
Matthew C Pickering, Vivette D D'Agati, Carla M Nester, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 27, 2021
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
Andrew S Bomback, Gerald B Appel, Debbie S Gipson, et al.
Page
of 14